Cornerstone National Bank & Trust’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5,000
Closed -$227K 62
2021
Q4
$227K Buy
+5,000
New +$261K 0.1% 62

Other funds holding CDNA

Cornerstone National Bank & Trust's CDNA Position: Q1 2022 in Review

Cornerstone National Bank & Trust sold out of CareDx (CDNA) in Q1 2022, closing a stake of 5,000 shares — an estimated $227K sold.

Cornerstone National Bank & Trust first reported a position in CDNA in Q4 2021 and held it in 1 quarter. The position peaked at $227K in Q4 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

  • Cornerstone National Bank & Trust reported no remaining CareDx position as of Q1 2022 after selling out during the quarter.
  • Cornerstone National Bank & Trust sold 5,000 CareDx shares in Q1 2022, an estimated $227K.
  • Cornerstone National Bank & Trust first reported a position in CareDx in Q4 2021 and held it in 1 quarter.
  • Cornerstone National Bank & Trust's CareDx position peaked at $227K in Q4 2021.
  • 213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Cornerstone National Bank & Trust's 13F filing for Q1 2022, filed 28 Jan 2026.